Powered by lexis nexis

Imprimis Pharmaceuticals to Raise $3.1 Million in Registered Direct Offering

Mar 22, 2017 - PR Newswire

 Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, announced today that it has entered into agreements with two accredited investors for a registered direct placement of 1,312,000 shares of common stock at a price of $2.40 per share for aggregate gross proceeds of $3,148,800.  The offering is expected to close on or about March 27, 2017, subject to satisfaction of customary closing conditions.

National Securities Corporation, a wholly owned s...